protectin D1
Selected indexed studies
- Protectin D1 Alleviates Myocardial Ischemia/Reperfusion Injury by Regulating PI3K/AKT Signaling Pathway. (J Cardiovasc Transl Res, 2024) [PMID:37580643]
- Protectin D1, an omega-3-derived lipid mediator, resolves mast cell-driven allergic inflammation via FcεRⅠ signaling. (Biomed Pharmacother, 2025) [PMID:40253829]
- Protectin D1 reduces imiquimod-induced psoriasiform skin inflammation. (Int Immunopharmacol, 2021) [PMID:34153674]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Protectin D1 Alleviates Myocardial Ischemia/Reperfusion Injury by Regulating PI3K/AKT Signaling Pathway. (2024) pubmed
- Protectin D1, an omega-3-derived lipid mediator, resolves mast cell-driven allergic inflammation via FcεRⅠ signaling. (2025) pubmed
- Protectin D1 reduces imiquimod-induced psoriasiform skin inflammation. (2021) pubmed
- Protectin D1 ameliorates non-compressive lumbar disc herniation through SIRT1-mediated CGRP signaling. (2024) pubmed
- Protectin D1 inhibits TLR4 signaling pathway to alleviate non-alcoholic steatohepatitis via upregulating IRAK-M. (2024) pubmed
- Confusion between protectin D1 (PD1) and its isomer protectin DX (PDX). An overview on the dihydroxy-docosatrienes described to date. (2014) pubmed
- Protectin D1 decreases pancreatitis severity in mice by inhibiting neutrophil extracellular trap formation. (2021) pubmed
- GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain. (2018) pubmed
- Protectin D1/GPR37 signaling enhances macrophage-dependent efferocytosis to attenuate experimental abdominal aortic aneurysm formation. (2025) pubmed
- Neuroprotectin D1 and GPR37 protect against chemotherapy-induced peripheral neuropathy and the transition from acute to chronic pain. (2025) pubmed